UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
HUMANA INC.
(Exact name of registrant as specified in its charter)
|
Delaware |
61-0647538 |
|
(State or other jurisdiction of |
(I.R.S. Employer |
500 West Main Street
Louisville, Kentucky 40202
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes X No ____
Indicate the number of shares outstanding of each of the issuer's classes of common stock as of the latest practicable date.
|
Class of Common Stock |
Outstanding at |
|
Humana Inc. |
|||
|
INDEX |
|||
|
Part I: Financial Information |
Page |
||
|
Item 1. |
Financial Statements |
||
|
Condensed Consolidated Balance Sheets at September 30, 2002 and December 31, 2001 |
3 |
||
|
4 |
|||
|
5 |
|||
|
6 |
|||
|
Item 2. |
Management's Discussion and Analysis of Financial Condition and Results |
15 |
|
|
Item 3. |
32 |
||
|
Item 4. |
32 |
||
|
Part II: Other Information |
|||
|
Item 1. |
33 |
||
|
Item 6. |
36 |
||
|
37 |
|||
|
38 |
|||
2
|
|
|
September 30, |
|
|
December 31, |
|
||||
|
|
|
2002 |
|
|
2001 |
|
||||
|
|
|
(Unaudited) |
|
|
(Audited) |
|
||||
|
|
|
(in thousands, except share amounts) |
|
|||||||
|
A SSETS |
||||||||||
|
Current assets: |
||||||||||
|
Cash and cash equivalents |
|
$ |
375,736 |
|
|
$ |
651,420 |
|
||
|
Investment securities |
|
|
1,420,524 |
|
|
|
1,389,596 |
|
||
|
Receivables, less allowance for doubtful accounts of $32,606 |
|
|
|
|
|
|
|
|
||
|
Premiums |
|
|
489,518 |
|
|
|
299,601 |
|
||
|
Administrative services fees |
|
|
67,762 |
|
|
|
26,667 |
|
||
|
Deferred income taxes |
|
|
50,691 |
|
|
|
64,221 |
|
||
|
Other |
|
|
180,272 |
|
|
|
191,433 |
|
||
|
|
|
|||||||||
|
Total current assets |
|
|
2,584,503 |
|
|
|
2,622,938 |
|
||
|
Property and equipment, net |
|
|
462,453 |
|
|
|
461,761 |
|
||
|
Other assets: |
|
|
|
|
|
|
|
|
||
|
Long-term investment securities |
|
|
317,346 |
|
|
|
280,320 |
|
||
|
Goodwill |
|
|
776,874 |
|
|
|
776,874 |
|
||
|
Deferred income taxes |
|
|
147 |
|
|
|
36,582 |
|
||
|
Other |
|
|
238,007 |
|
|
|
225,163 |
|
||
|
|
|
|
||||||||
|
Total other assets |
|
|
1,332,374 |
|
|
|
1,318,939 |
|
||
|
|
|
|
|
|
|
|
||||
|
Total assets |
|
$ |
4,379,330 |
|
|
$ |
4,403,638 |
|
||
|
|
|
|||||||||
|
L IABILITIES AND STOCKHOLDERS' EQUITY |
||||||||||
|
Current liabilities: |
||||||||||
|
Medical and other expenses payable |
|
$ |
1,164,431 |
|
|
$ |
1,086,386 |
|
||
|
Trade accounts payable and accrued expenses |
|
|
475,885 |
|
|
|
479,996 |
|
||
|
Book overdraft |
|
|
104,402 |
|
|
|
152,757 |
|
||
|
Unearned premium revenues |
|
|
89,977 |
|
|
|
325,040 |
|
||
|
Short-term debt |
|
|
265,000 |
|
|
|
263,000 |
|
||
|
|
|
|||||||||
|
Total current liabilities |
|
|
2,099,695 |
|
|
|
2,307,179 |
|
||
|
|
|
|
|
|
|
|
||||
|
Long-term debt |
|
|
334,061 |
|
|
|
315,489 |
|
||
|
Professional liability risks |
|
|
247,690 |
|
|
|
241,431 |
|
||
|
Other long-term obligations |
|
|
30,440 |
|
|
|
31,590 |
|
||
|
|
|
|||||||||
|
Total liabilities |
|
|
2,711,886 |
|
|
|
2,895,689 |
|
||
|
|
|
|||||||||
|
Commitments and contingencies |
||||||||||
|
Stockholders' equity: |
||||||||||
|
Preferred stock, $1 par; 10,000,000 shares authorized, none issued |
|
|
- |
|
|
|
- |
|
||
|
Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 171,303,567 shares issued in 2002 and 170,692,520 sharesissued in 2001 |
|
|
28,551 |
|
|
|
28,449 |
|
||
|
Capital in excess of par value |
|
|
930,942 |
|
|
|
922,439 |
|
||
|
Retained earnings |
|
|
722,583 |
|
|
|
578,122 |
|
||
|
Accumulated other comprehensive income |
|
|
35,819 |
|
|
|
11,670 |
|
||
|
Unearned stock compensation |
|
|
(9,059 |
) |
|
|
(17,882 |
) |
||
|
Treasury stock, at cost, 4,028,137 shares in 2002 and 1,880,619 |
|
|
(41,392 |
) |
|
|
(14,849 |
) |
||
|
|
|
|||||||||
|
Total stockholders' equity |
|
|
1,667,444 |
|
|
|
1,507,949 |
|
||
|
|
|
|||||||||
|
Total liabilities and stockholders' equity |
|
$ |
4,379,330 |
|
|
$ |
4,403,638 |
|
||
|
|
|
|||||||||
|
See accompanying notes to condensed consolidated financial statements. |
||||||||||
3
|
Humana Inc. |
|||||||||||||
|
Three months ended |
Nine months ended |
||||||||||||
|
2002 |
2001 |
2002 |
2001 |
||||||||||
|
(in thousands, except per share results) |
|||||||||||||
|
Revenues: |
|||||||||||||
|
Premiums |
$ |
2,752,336 |
$ |
2,541,483 |
$ |
8,137,887 |
$ |
7,394,575 |
|||||
|
Administrative services fees |
61,056 |
39,943 |
189,900 |
87,773 |
|||||||||
|
Investment and other income |
28,235 |
29,448 |
78,362 |
89,822 |
|||||||||
|
|
|
|
|
||||||||||
|
Total revenues |
2,841,627 |
2,610,874 |
8,406,149 |
7,572,170 |
|||||||||
|
|
|
|
|
||||||||||
|
Operating expenses: |
|||||||||||||
|
Medical |
2,301,021 |
2,117,283 |
6,811,748 |
6,171,657 |
|||||||||
|
Selling, general and administrative |
429,019 |
398,799 |
1,278,516 |
1,132,660 |
|||||||||
|
Depreciation and amortization |
30,523 |
41,456 |
90,556 |
119,161 |
|||||||||
|
|
|
|
|
||||||||||
|
Total operating expenses |
2,760,563 |
2,557,538 |
8,180,820 |
7,423,478 |
|||||||||
|
|
|
|
|
||||||||||
|
Income from operations |
81,064 |
53,336 |
225,329 |
148,692 |
|||||||||
|
Interest expense |
4,107 |
5,945 |
12,888 |
20,468 |
|||||||||
|
|
|
|
|
||||||||||
|
Income before income taxes |
76,957 |
47,391 |
212,441 |
128,224 |
|||||||||
|
Provision for income taxes |
24,626 |
17,061 |
67,981 |
46,161 |
|||||||||
|
|
|
|
|
||||||||||
|
Net income |
$ |
52,331 |
$ |
30,330 |
$ |
144,460 |
$ |
82,063 |
|||||
|
|
|
|
|
||||||||||
|
Basic earnings per common share |
$ |
0.32 |
$ |
0.18 |
$ |
0.88 |
$ |
0.50 |
|||||
|
|
|
|
|
||||||||||
|
Diluted earnings per common share |
$ |
0.31 |
$ |
0.18 |
$ |
0.86 |
$ |
0.49 |
|||||
|
|
|
|
|
||||||||||
|
See accompanying notes to condensed consolidated financial statements. |
|||||||||||||
4
|
Humana Inc. |
|||||||
|
Nine months ended |
|||||||
|
2002 |
2001 |
||||||
|
(in thousands) |
|||||||
|
Cash flows from operating activities |
|||||||
|
Net income |
$ |
144,460 |
$ |
82,063 |
|||
|
Adjustments to reconcile net income |
|||||||
|
Depreciation and amortization |
90,556 |
119,161 |
|||||
|
Provision for deferred income taxes |
34,221 |
40,288 |
|||||
|
Payment for government audit settlement |
- |
(8,000 |
) |
||||
|
Changes in operating assets and liabilities: |
|||||||
|
Receivables |
(231,012 |
) |
14,251 |
||||
|
Other assets |
268 |
13,839 |
|||||
|
Medical and other expenses payable |
78,045 |
(155,907 |
) |
||||
|
Other liabilities |
4,742 |
10,236 |
|||||
|
Unearned premium revenues |
(235,063 |
) |
(55,491 |
) |
|||
|
Other |
12,481 |
(602 |
) |
||||
|
|
|
||||||
|
Net cash (used in) provided by operating activities |
(101,302 |
) |
59,838 |
||||
|
|
|
||||||
|
Cash flows from investing activities |
|||||||
|
Acquisitions, net of cash and cash equivalents acquired |
- |
(32,700 |
) |
||||
|
Divestitures, net of cash and cash equivalents disposed |
1,109 |
1,050 |
|||||
|
Purchases of property and equipment |
(83,581 |
) |
(82,173 |
) |
|||
|
Purchases of investment securities |
(1,639,803 |
) |
(1,359,676 |
) |
|||
|
Maturities of investment securities |
273,199 |
421,498 |
|||||
|
Proceeds from sales of investment securities |
1,339,124 |
964,520 |
|||||
|
|
|
||||||
|
Net cash used in investing activities |
(109,952 |
) |
(87,481 |
) |
|||
|
|
|
||||||
|
Cash flows from financing activities |
|||||||
|
Net revolving credit agreement repayments |
- |
(250,000 |
) |
||||
|
Net commercial paper conduit borrowings |
2,000 |
- |
|||||
|
Net commercial paper repayments |
- |
(79,952 |
) |
||||
|
Proceeds from issuance of senior notes |
- |
299,277 |
|||||
|
Proceeds from other borrowings |
- |
5,700 |
|||||
|
Debt issue costs |
(559 |
) |
(3,240 |
) |
|||
|
Change in book overdraft |
(48,355 |
) |
(7,630 |
) |
|||
|
Common stock repurchases |
(25,439 |
) |
(1,867 |
) |
|||
|
Other |
7,923 |
(374 |
) |
||||
|
|
|
||||||
|
Net cash used in financing activities |
(64,430 |
) |
(38,086 |
) |
|||
|
|
|
||||||
|
Decrease in cash and cash equivalents |
(275,684 |
) |
(65,729 |
) |
|||
|
Cash and cash equivalents at beginning of period |
651,420 |
657,562 |
|||||
|
|
|
||||||
|
Cash and cash equivalents at end of period |
$ |
375,736 |
$ |
591,833 |
|||
|
|
|
||||||
|
Supplemental cash flow disclosures: |
|||||||
|
Interest payments |
$ |
8,099 |
$ |
20,193 |
|||
|
Income tax payments, net |
$ |
25,552 |
$ |
2,534 |
|||
|
See accompanying notes to condensed consolidated financial statements. |
|||||||
5
|
Humana Inc. |
(1) Basis of Presentation
The accompanying condensed consolidated financial statements are presented in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the disclosures normally required by accounting principles generally accepted in the United States of America, or those normally made in an Annual Report on Form 10-K. References throughout this document to "we," "us," "our," the "Company," and "Humana," mean Humana Inc. and all entities we own. For further information, the reader of this Form 10-Q should refer to our Form 10-K for the year ended December 31, 2001, that was filed with the Securities and Exchange Commission, or the SEC, on March 28, 2002, as well as the Form S-3 Registration Statement that we filed with the SEC on October 8, 2002.
The preparation of our condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although our estimates are based on knowledge of current events and anticipated future events, actual results may ultimately differ materially from those estimates.
The financial information has been prepared in accordance with our customary accounting practices and has not been audited. In our opinion, the information presented reflects all adjustments necessary for a fair statement of interim results. All such adjustments are of a normal and recurring nature. We have reclassified certain items in the prior year's condensed consolidated financial statements to conform with the current year presentation. These adjustments had no effect on previously reported consolidated net income or stockholders' equity.
On January 1, 2002, we adopted Statement of Financial Accounting Standards No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, or Statement 144. Statement 144 develops a single accounting model for long-lived assets to be disposed of by sale, addresses significant implementation issues related to previous guidance, and requires that long-lived assets to be disposed of by sale be measured at the lower of their carrying amount or fair value less cost to sell, whether reported in continuing operations or in discontinued operations. The adoption of Statement No. 144 did not have a material impact on our financial position, results of operations or cash flows.
The Financial Accounting Standards Board, or FASB, issued Statement of Financial Accounting Standards No. 146, or Statement 146, Accounting for Exit or Disposal Activities. Statement 146 addresses the recognition, measurement, and reporting of costs that are associated with exit and disposal activities, including certain lease termination costs and severance-type costs under a one-time benefit arrangement rather than an ongoing benefit arrangement or an individual deferred-compensation contract. Statement 146 requires liabilities associated with exit and disposal activities to be expensed as incurred and will impact the timing of recognition for exit or disposal activities that are initiated after December 31, 2002.
(2) Goodwill and Other Intangible Assets
In June 2001, the FASB issued Statement of Financial Accounting Standards No. 141, Business Combinations, or Statement 141, and Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets, or Statement 142. Statement 141 requires that all business combinations initiated after June 30, 2001 be accounted for using the purchase method. Use of the pooling-of-interest method is no longer permitted. Statement 142 requires that goodwill no longer be amortized to earnings, but instead be reviewed at least annually for impairment using a two-step process. The first step is a screen for potential impairment, and the second step measures the amount of impairment, if any. Impairment losses that arise from completing a transitional impairment test during 2002 are to be reported as the cumulative effect of a change in accounting principle at the beginning of the year. Subsequent impairments, if any, would be classified as an operating expense . Statement 142 also specifies the types of acquired intangible assets that are required to be recognized and reported separately from goodwill.
6
|
Humana Inc. |
We ceased amortizing goodwill upon adopting Statement 142 on January 1, 2002. We completed the transitional goodwill impairment test, which did not result in an impairment loss. Subsequent impairment tests will be performed, at a minimum, in the fourth quarter of each year in connection with the annual planning process. We allocated goodwill of $633.2 million to the Commercial segment and $143.7 million to the Government segment for purposes of completing the impairment test.
The following table adjusts net income and basic and diluted earnings per common share for the three and nine months ended September 30, 2002 and 2001 to reflect the non-amortization of goodwill assuming the non-amortization provisions of Statement 142 were adopted as of January 1, 2001:
|
Three months ended |
Nine months ended |
||||||||||||
|
2002 |
2001 |
2002 |
2001 |
||||||||||
|
(in thousands, except per share results) |
|||||||||||||
|
Net income: |
|||||||||||||
|
Reported net income |
$ |
52,331 |
$ |
30,330 |
$ |
144,460 |
$ |
82,063 |
|||||
|
Add back: goodwill amortization expense, |
- |
13,184 |
- |
39,073 |
|||||||||
|
|
|
|
|
||||||||||
|
Adjusted net income |
$ |
52,331 |
$ |
43,514 |
$ |
144,460 |
$ |
121,136 |
|||||
|
|
|
|
|
||||||||||
|
Basic earnings per common share: |
|||||||||||||
|
Reported basic earnings per common share |
$ |
0.32 |
$ |
0.18 |
$ |
0.88 |
$ |
0.50 |
|||||
|
Add back: goodwill amortization expense, |
- |
0.08 |
- |
0.24 |
|||||||||
|
|
|
|
|
||||||||||
|
Adjusted basic earnings per common share |
$ |
0.32 |
$ |
0.27 |
$ |
0.88 |
$ |
0.74 |
|||||
|
|
|
|
|
||||||||||
|
Diluted earnings per common share: |
|||||||||||||
|
Reported diluted earnings per common share |
$ |
0.31 |
$ |
0.18 |
$ |
0.86 |
$ |
0.49 |
|||||
|
Add back: goodwill amortization expense, |
- |
0.08 |
- |
0.23 |
|||||||||
|
|
|
|
|
||||||||||
|
Adjusted diluted earnings per common share |
$ |
0.31 |
$ |
0.26 |
$ |
0.86 |
$ |
0.73 |
|||||
|
|
|
|
|
||||||||||
We amortize other intangible assets over their estimated useful lives ranging from 2 to 20 years, with a weighted average life of 8.6 years. Other intangible assets primarily relate to acquired subscriber, provider, and government contracts, and the cost of acquired licenses and are included with other long-term assets in the condensed consolidated balance sheets. Amortization expense for other intangible assets was approximately $3.9 million and $11.8 million for the three and nine months ended September 30, 2002, respectively, and $4.0 million and $9.4 million for the three and nine months ended September 30, 2001, respectively. The following table presents our estimate of amortization expense for all of 2002, and for each of the five succeeding fiscal years:
|
(in thousands) |
||||
|
For the years ended December 31: |
||||
|
2002 |
$ |
15,724 |
||
|
2003 |
$ |
11,612 |
||
|
2004 |
$ |
9,060 |
||
|
2005 |
$ |
5,440 |
||
|
2006 |
$ |
352 |
||
|
2007 |
$ |
352 |
||
7
|
Humana Inc. |
The following table presents details of our other intangible assets at September 30, 2002 and December 31, 2001:
|
|
September 30, 2002 |
|
December 31, 2001 |
||||||||||||||
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
Accumulated |
|
|
|
|||
|
|
Cost |
|
Amortization |
|
Net |
|
Cost |
|
Amortization |
|
Net |
||||||
|
|
(in thousands) |
||||||||||||||||
|
Other intangible assets: |
|||||||||||||||||
|
Subscriber contracts |
$ |
85,496 |
|
$ |
66,556 |
|
$ |
18,940 |
|
$ |
85,496 |
|
$ |
61,374 |
|
$ |
24,122 |
|
Provider contracts |
|
12,128 |
|
|
5,036 |
|
|
7,092 |
|
|
12,128 |
|
|
3,212 |
|
|
8,916 |
|
Government contracts |
|
11,820 |
|
|
8,222 |
|
|
3,598 |
|
|
11,820 |
|
|
3,597 |
|
|
8,223 |
|
Licenses and other |
|
5,065 |
|
|
1,107 |
|
|
3,958 |
|
|
5,065 |
|
|
945 |
|
|
4,120 |
|
|
|
|
|
|
|
||||||||||||
|
Total other intangible assets |
$ |
||||||||||||||||